PhD Position in Medical Physics and Radiopharmaceutical Sciences
- German Cancer Research Center (DKFZ)
- Closing date
- 15 Dec 2023
Are you interested in applying physical and (radio)chemical methods in cancer research during your PhD? The German Cancer Research Center (DKFZ) in Heidelberg, Germany’s largest biomedical research institute, has its own multidisciplinary research program dedicated to “Imaging and Radiooncology”. This research program is concerned with introducing new findings, methods and technologies into the diagnosis and treatment of cancer. Physicists, mathematicians, computer scientists, engineers, biologists, pharmacists and chemists strongly collaborate to tailor tumor treatment to the individual patient and to improve possibilities of local and systemic tumor control.
Main research activities are focused on:
- Development of novel approaches in diagnostics and therapy, based on physical methods;
- Non-invasive imaging technologies such as CT, MRI, PET/CT, PET/MRI and radiation therapy technologies;
- Radiotracer and radiopharmaceutical drug development including radiochemistry and nuclear chemistry to target cancer cells;
- Transfer of novel systemic therapeutic and diagnostic methods into a clinical setting.
More information about the groups and their research can be found here.
Full funding is provided for the duration of the PhD.
To apply online to the International PhD Program visit: http://www.dkfz.de/en/phd-program/index.html?campaign=phd/bright
Application deadlines: 15 May and 15 December each year.
The German Cancer Research Center (DKFZ) in Heidelberg is Germany’s largest biomedical research institute. As part of the Helmholtz Association, the largest research organization in Germany, the DKFZ has an international and dynamic work environment, providing scientists with access to state-of-the-art research facilities and exceptional resources.
German Cancer Research Center (DKFZ)
Im Neuenheimer Feld 280
Get job alerts
Create a job alert and receive personalised job recommendations straight to your inbox.Create alert